These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 2652529

  • 1. Is long-term triple drug therapy required for maintaining kidney allograft tolerance? Effect of azathioprine withdrawal at three months posttransplantation.
    Oncevski A, Rostoker G, Buisson C, Fruchaud G, Benmaadi A, Belghiti D, Chopin D, Abbou C, Bierling P, Romano P.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1625-6. PubMed ID: 2652529
    [No Abstract] [Full Text] [Related]

  • 2. The impact of quadruple versus triple drug immunosuppression on clinical results of cadaver renal transplantation.
    Rao KV, Andersen RC.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1652. PubMed ID: 2652540
    [No Abstract] [Full Text] [Related]

  • 3. Low-dose cyclosporin, prednisolone and anti-lymphocyte globulin immunosuppressive treatment in cadaveric kidney transplantation.
    Ono Y, Ohshima S, Fujita T, Kinukawa T, Matsuura O, Hirabayashi S, Takeuchi N.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1657-9. PubMed ID: 2652543
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Trends in immunosuppression for kidney transplantation.
    Butt KM, Zielinski CM, Parsa I, Elberg AJ, Wechter W, Kountz SL.
    Kidney Int Suppl; 1978 Jun; (8):S95-8. PubMed ID: 357820
    [No Abstract] [Full Text] [Related]

  • 8. The efficacy of bolus doses of intravenous methylprednisolone (MPIV) in the treatment of acute renal allograft rejection.
    Kountz SL, Rao TK, Butt KH.
    Transplant Proc; 1975 Mar; 7(1):73-7. PubMed ID: 1091048
    [No Abstract] [Full Text] [Related]

  • 9. Intraoperative high-dose anti-T-lymphocyte globulin bolus in addition to triple-drug therapy improves kidney graft survival.
    Kaden J, May G, Müller P, Groth J, Strobelt V, Eger E, Wohlfahrt L.
    Transplant Proc; 1995 Feb; 27(1):1060-1. PubMed ID: 7878804
    [No Abstract] [Full Text] [Related]

  • 10. Pediatric renal transplantation results are improved with triple drug therapy with cyclosporine, azathioprine, and prednisone.
    MacDonell RC, Johnson K, Richie R, Nylander W, McMahon Y, Niblack G, Green W, Morrissey J, Ynares C.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1701-4. PubMed ID: 2652557
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Long-term outcome after switch from cyclosporine-based triple-drug immunosuppression to double therapy at three months.
    Aichberger C, Eberl T, Riedmann B, Pernthaler H, Ofner D, Königsrainer A, Margreiter R.
    Clin Transplant; 1996 Apr; 10(2):209-12. PubMed ID: 8664521
    [Abstract] [Full Text] [Related]

  • 15. Initiation of ALG pretransplant reduces the incidence of delayed renal allograft function.
    Hong JH, Sumrani N, Cacciarelli TV, Distant D, Sommer BG.
    Transplant Proc; 1993 Feb; 25(1 Pt 1):581-2. PubMed ID: 8438423
    [No Abstract] [Full Text] [Related]

  • 16. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
    Guttmann RD, Flemming C.
    Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Quadruple drug therapy prevents graft loss from acute rejection without increasing mortality.
    Light JA, Aquino A, Ali A, Rodriguez R, Ali S.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1927-30. PubMed ID: 3547897
    [No Abstract] [Full Text] [Related]

  • 20. Cyclosporine-steroids versus conventional therapy in cadaver kidney transplantation: analysis of a randomized trial at two years.
    Gianello P, Squifflet JP, Pirson Y, Stoffel M, Dereme T, Alexandre GP.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1867-72. PubMed ID: 3547891
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.